article thumbnail

Impact of Heart Transplant Allocation Changes on Waitlist Mortality and Clinical Practice in Pediatric and Adult Patients With Congenital Heart Disease and Cardiomyopathy

Circulation

BACKGROUND:The United Network of Organ Sharing made changes to the priority for allocation of hearts for transplantation (HT) in 2016 for pediatric patients and 2018 for adult patients. Circulation, Ahead of Print.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. et al (2016). 5 Kutty, S.,

article thumbnail

J&J Expands Into Interventional HF Treatments With V-Wave Acquisition

CardiacWire

The two companies are already well-acquainted, as J&J led V-Wave’s 2016 Series B and was involved in subsequent rounds. These improvements would allow the Ventura IAS to address the notable HFrEF treatment gap between GDMT and far more invasive therapies like LVAD and heart transplantation. An estimated 800k U.S.

article thumbnail

Abstract 4146823: Trends and Outcomes in Heart Failure Admissions and Cardiogenic Shock Among Patients with Congenital Heart Disease

Circulation

CHD admissions remained stable from 2016 to 2020. Heart transplant rates were low but increased slightly in 2020 for patients without CHD, with DV and SV CHD patients showing fluctuating rates peaking in 2018 and 2019, then declining in 2020.

article thumbnail

Abstract 4134590: Procedural Related Major Adverse Events of Cardiac Catheterization in Pediatric Patients with Cardiomyopathy: Insights from IMPACT Registry

Circulation

The association between a lower rate of MAE and EMB persisted in the multivariate model when those with heart transplant who had EMB were compared to those without heart transplant who did not have EMB p=0.001. We collected demographic, pre-procedural, procedural, and outcome-related variables. were females.

article thumbnail

Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions

Circulation: Heart Failure

Centers performing at least 1 heart transplant or left ventricular assist device were classified as ATCs. Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs.

article thumbnail

A young lady with wide complex tachycardia. My first time actually making this diagnosis de novo in real life in the ED!

Dr. Smith's ECG Blog

J Electrocardiol, 42 (2009), pp. e5 Article Download PDF Google Scholar 3 RNW Hauer, MGPJ Cox, JA Groeneweg Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy Front Physiol, 3 (2012), p. Hz to 150 H z) is recommended for diagnostic mode , where more accurate ST segment analysis is essential.